Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 5/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.38 |
| ▸ | PTGES | O14684 | 4/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18906944 | 0.79 | GRIN2D (0.40) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL18906949 | 0.78 | PTGS1 (0.31) | — | |
| SCHEMBL9906098 | 0.77 | LMNA (0.53) | — | |
| SCHEMBL18913787 | 0.76 | GRIN2D (0.42) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL18913729 | 0.74 | CYP19A1 (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1629312 | 0.72 | LMNA (0.55) | — | |
| SCHEMBL15284755 | 0.72 | HDAC3 (0.50) | LIMK2 | |
| SCHEMBL22542298 | 0.70 | ALDH1A1 (0.50) | — | |
| SCHEMBL28301405 | 0.70 | HDAC6 (0.54) | LIMK2LIMK1 | |
| SCHEMBL11964294 | 0.69 | HSD11B1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005856-B2 | Curable composition | FUJIFILM CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-3187516-A1 | CURABLE COMPOSITION, CURED PRODUCT OF FUNCTIONAL POLYMER, STACK OR DEVICE PROVIDED WITH FUNCTIONAL POLYMER FILM, AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | Fujifilm Corporation (JP) | 2017-07-05 | — | — | EP | disclosed |
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | ASH2L, VMA21, SGMS1 | GRIN2D 316/4885GRIN3B 514/4885GRIN1 115/4885 |
| US-10005856-B2 | Curable composition | ASH2L, ASH1L, CHRM1 | GRIN2D 885/4885GRIN3B 684/4885GRIN1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.